Pharmacological characterization of thromboxane and prostanoid receptors in human isolated urinary bladder

被引:61
作者
Palea, S
Toson, G
Pietra, C
Trist, DG
Artibani, W
Romano, O
Corsi, M
机构
[1] Glaxo Wellcome, Med Res Ctr, Verona, Italy
[2] Univ Padua, Dept Urol, Padua, Italy
关键词
human urinary bladder; detrusor; smooth muscle contraction; TXA(2) receptors; prostanoid receptors; electrical held stimulation; acetylcholine release; vapiprost; U-46619; prostaglandin E-2; prostaglandin F-2 alpha;
D O I
10.1038/sj.bjp.0701903
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
1 Cumulative concentration-response curves (CRC) to prostaglandin E-1 (PGE(1)), PGE(2), PGD(2) and PGF(2 alpha) (0.01-30 mu M) and to the thromboxane A(2) (TXA(2)) receptor agonist U-46619 (0.01-30 mu M) were constructed in human isolated detrusor muscle strips both in basal conditions and during electrical field stimulation. 2 All the agonists tested contracted the detrusor muscle. The rank order of agonist potency was: PGF(2 alpha) >U-46619 >PGE(2) whereas weak contractile responses were obtained with PGD(2) and PGE(1). Any of the agonists tested was able to induce a clear plateau of response even at 30 mu M. 3 The selective TXA(2) antagonist, GR 32191B (vapiprost), antagonized U-46619-induced contractions with an apparent pK(B) value of 8.27+/-0.12 (n=4 for each antagonist concentration). GR 32191B (0.3 mu M) did not antagonize the contractile responses to PGF(2 alpha) and it was a non-surmountable antagonist of PGE1 (apparent pKB of 7.09+/-0.04; n=5). The EP receptor antagonist AH 6809 at 10 mu M shifted to the right the CRC to U-46619 (apparent pKB value of 5.88+/-0.04; n=4). 4 Electrical field stimulation (20 Hz, 70 V, pulse width 0.1 ms, trains of 5 s every 60 s) elicited contractions fully sensitive to TTX (0.3 mu M) and atropine (1 mu M). U-46619 (0.01-3 mu M) potentiated the twitch contraction in a dose-dependent manner and this effect was competitively antagonized by GR 32191B with an estimated pKB of 8.54 +/- 0.14 (n = 4 for each antagonist concentration). PGF(2 alpha) in the range 0.01-10 mu M (n=7), but not PGE2 and PGE(1) (n=3 for each), also potentiated the twitch contraction of detrusor muscle strips (23.5+/-0.3% of KCl 100 mM-induced contraction) but this potentiation was unaffected by 0.3 mu M GR 32191B (n= 5). 5 Cumulative additions of U-46619 (0.01-30 mu M) were without effect on contractions induced by direct smooth muscle excitation (20 Hz, 40 V, 6 ms pulse width, trains of 2 s every 60 s, in the presence of TTX 1 mu M; n=3). Moreover, pretreatment of the tissue with 0.3 mu M U-46619 did not potentiate the smooth muscle response to 7 mu M bethanecol (n=2). 6 We concluded that TXA(2) can induce direct contraction of human isolated urinary bladder through the classical TXA2 receptor. Prostanoid receptors, fully activated by PGE(2) and PGF(2 alpha) are also present. All these receptors are probably located post-junctionally. The rank order of agonist potency and the fact that GR32191B, but not AH6809, antagonized responses to PGE2 seem to indicate the presence of a new EP receptor subtype. Moreover, we suggest the presence of prejuctional TXA2 and FP receptors, potentiating acetylcholine release from cholinergic nerve terminals.
引用
收藏
页码:865 / 872
页数:8
相关论文
共 35 条
[1]   ACTIONS OF PROSTAGLANDINS ON SMOOTH-MUSCLE OF HUMAN URINARY-TRACT INVITRO [J].
ABRAMS, PH ;
FENELEY, RCL .
BRITISH JOURNAL OF UROLOGY, 1975, 47 (07) :909-915
[2]  
ABRAMS PH, 1979, INVEST UROL, V16, P346
[3]   EFFECTS OF PROSTAGLANDINS ON ISOLATED HUMAN BLADDER AND URETHRA [J].
ANDERSSON, KE ;
EK, A ;
PERSSON, CGA .
ACTA PHYSIOLOGICA SCANDINAVICA, 1977, 100 (02) :165-171
[4]   SOME QUANTITATIVE USES OF DRUG ANTAGONISTS [J].
ARUNLAKSHANA, O ;
SCHILD, HO .
BRITISH JOURNAL OF PHARMACOLOGY AND CHEMOTHERAPY, 1959, 14 (01) :48-58
[5]   CHARACTERIZATION OF THE PROSTANOID RECEPTORS MEDIATING CONSTRICTION AND RELAXATION OF HUMAN ISOLATED UTERINE ARTERY [J].
BAXTER, GS ;
CLAYTON, JK ;
COLEMAN, RA ;
MARSHALL, K ;
SANGHA, R ;
SENIOR, J .
BRITISH JOURNAL OF PHARMACOLOGY, 1995, 116 (01) :1692-1696
[6]   Molecular cloning and characterization of the four rat prostaglandin E2 prostanoid receptor subtypes [J].
Boie, Y ;
Stocco, R ;
Sawyer, N ;
Slipetz, DM ;
Ungrin, MD ;
Neuschäfer-Rube, F ;
Püschel, GP ;
Metters, KM ;
Abramovitz, M .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1997, 340 (2-3) :227-241
[7]   A NOVEL INHIBITORY PROSTANOID RECEPTOR IN PIGLET SAPHENOUS-VEIN [J].
COLEMAN, RA ;
GRIX, SP ;
HEAD, SA ;
LOUTTIT, JB ;
MALLETT, A ;
SHELDRICK, RLG .
PROSTAGLANDINS, 1994, 47 (02) :151-168
[8]   COMPARISON OF THE ACTIONS OF U-46619, A PROSTAGLANDIN H2-ANALOGUE, WITH THOSE OF PROSTAGLANDIN-H2 AND THROMBOXANE-A2 ON SOME ISOLATED SMOOTH-MUSCLE PREPARATIONS [J].
COLEMAN, RA ;
HUMPHREY, PPA ;
KENNEDY, I ;
LEVY, GP ;
LUMLEY, P .
BRITISH JOURNAL OF PHARMACOLOGY, 1981, 73 (03) :773-778
[9]  
COLEMAN RA, 1990, COMPREHENSIVE MED CH, V3, P643
[10]  
DELEAN A, 1978, AM J PHYSIOL, V235, P97